LAB financial statements and SEC filings
LAB annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $85.33M | -$110.25M | -$74.90M | 10-K |
| 2024-12-31 | $91.01M | -$127.48M | -$184.90M | 10-K |
| 2023-12-31 | $106.34M | -$76.60M | -$74.66M | 10-K |
| 2022-12-31 | $97.95M | -$116.20M | -$190.10M | 10-K |
| 2021-12-31 | $130.58M | -$67.46M | -$59.24M | 10-K |
| 2020-12-31 | $138.14M | -$51.04M | -$53.02M | 10-K |
LAB annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $567.75M | $143.46M | $424.29M | 10-Q |
| 2024-12-31 | $612.35M | $140.62M | $471.72M | 10-K |
| 2023-12-31 | $323.07M | $159.87M | -$148.05M | 10-K |
| 2022-12-31 | $390.31M | $160.52M | -$81.47M | 10-K |
| 2021-12-31 | $275.21M | $180.62M | $94.60M | 10-K |
| 2020-12-31 | $324.76M | $185.71M | $139.05M | 10-K |
LAB annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | -$74.34M | -$8.30M | $570.00K | 10-K |
| 2024-12-31 | -$143.45M | -$8.36M | -$102.62M | 10-K |
| 2023-12-31 | -$43.29M | -$2.83M | -$6.81M | 10-K |
| 2022-12-31 | -$89.37M | -$3.83M | $230.76M | 10-K |
| 2021-12-31 | -$44.06M | -$13.26M | $15.96M | 10-K |
| 2020-12-31 | -$15.42M | -$12.72M | $20.86M | 10-K |